Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0793
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2615
    -0.0007 (-0.06%)
     
  • USD/JPY

    151.3400
    -0.0320 (-0.02%)
     
  • Bitcoin USD

    70,275.08
    -448.45 (-0.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Equinor (EQNR) to Boost Johan Sverdrup Crude Oil Production

Equinor ASA EQNR recently announced plans to boost crude oil from its leading Johan Sverdrup field. The company intends to increase output from the field to 500,000 barrels of oil per day (bpd) by 2020-end, indicating a rise of 60,000 bpd from its initial capacity.

The company tested the plant capacity this month for a potential production increase, which yielded positive results. The execution of the latest plan will mark the second output capacity increase from the field. Notably, the current production capacity at the site stands at 470,000 bpd. The Johan Sverdrup is a field with low emissions and operating costs. The full-field development break-even price is under $20 per barrel.

The phase two development of the field is on schedule, which is expected to commence production in fourth-quarter 2022. A total production capacity of 720,000 bpd will be attained from the Johan Sverdrup field. To ensure high recovery of reserves, Equinor is using water injection at the site. Moreover, it expects higher water injection capacity to enable the company to boost output to more than 500,000 bpd by mid-2021.

Notably, Johan Sverdrup is expected to have resources of 2.7 billion barrels of oil equivalent. It is marked as the third-largest oil field in the Norwegian continental shelf. While Equinor holds a 42.6% operating stake at the field, Lundin Energy Norway and Petorohave 20% and 17.36% interests, respectively. The remaining stake in the field is held by Aker BP and TOTAL SE TOT.

Price Performance

Equinor’s stock has increased 0.2% in the past six months compared with 8.8% rise of the industry it belongs to.

Zacks Rank & Stocks to Consider

The company currently has a Zacks Rank #3 (Hold). Some better-ranked players in the energy space include Antero Resources Corporation AR and Global Partners LP GLP, each holding a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Antero Resources’ bottom line for 2021 is expected to rise 30.5% year over year.

Global Partners’ bottom line for 2020 is expected to rise 150.5% year over year.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
TOTAL SE (TOT) : Free Stock Analysis Report
 
Global Partners LP (GLP) : Free Stock Analysis Report
 
Antero Resources Corporation (AR) : Free Stock Analysis Report
 
Equinor ASA (EQNR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement